Trial intelligence / Profile preview

ENOS: Efficacy of Nitric Oxide in Stroke

2004-003870-27Phase 3Completed

Sponsor
University of Nottingham
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in ischemic stroke, brain hemorrhage (ICH) and hypertension (HTN) comparing Nitroglycerin with Placebo/Standard blood pressure management (2 arms). Primary endpoint: modified Rankin Scale at 90 days. Started Jul 2008; status: completed.

02

Drugs

nitroglycerin
03

Conditions

ischemic strokebrain hemorrhage (ICH)hypertension (HTN)

Beyond the preview

Go deeper on 2004-003870-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-003870-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call